Dr Shalini Arunogiri

Dr Shalini Arunogiri 

MBBS (Hons), PhD, FRANZCP Cert Addiction Psychiatry (Addiction Studies), MPsychiatry

Dr Shalini Arunogiri is Deputy Head of Department, Psychiatry (CCS), Monash University, and a consultant addiction psychiatrist and clinician-researcher.

Shalini’s research interest stemmed from her work with patients and families affected by methamphetamine use. Her PhD focused on methamphetamine psychosis, a particularly damaging consequence of ice use that affects many, and her work shed light on its correlates and risk factors. Shalini’s research program now encompasses methamphetamine use and mental health co-morbidity, women’s health and addiction, and medication treatments for addictive disorders. She is an investigator on the only Melbourne site for three medication trials in addiction (DEBUT- depot buprenorphine for opioid use disorders; LiMA- Lisdexamfetamine for Methamphetamine; and N-ICE, N-Acetylcysteine for ice). Shalini has over 35 peer-reviewed publications and attracted over 1M of research funding to date.

Clinically, Shalini leads a team of over 50 multidisciplinary clinicians in the delivery of face-to-face, telephone and online addiction treatment at Turning Point. Her clinical work is primarily in assessment and treatment of mental health problems co-occurring with addiction. She also mentors and supervises students and clinical staff from a range of disciplines, and is available for supervision of honours, masters and PhD students with aligned interests.

Stigma is a major barrier to care in addiction, and Shalini actively advocates for safe, effective, evidence-based and equitable addiction treatment in Australia. She is currently Chair of the Binational Faculty of Addiction Psychiatry at the Royal Australian and New Zealand College of Psychiatrists (RANZCP), the peak body for psychiatrists in the region, shaping the organisation’s policy and practice responses in addiction. Shalini also holds leadership roles in international organisations, including the International Society of Addiction Medicine (Co-Chair of the Policy and Practice Interest Group).

Shalini is active on social media, and is the current Social Media Editor for the American Journal of Drug and Alcohol Abuse and the International Society of Addiction Medicine. She shares her own research, and engages with others’, through her own twitter @SArunogiri. Shalini is also a passionate advocate for minority women in academia and medicine. She is a proud mother of an energetic four -year-old boy.


 MAPrc Multidisciplinary Alfred Psychiatry Research Centre, Level 4, 607 St Kilda Road, Melbourne 3004